Chitosan-Functionalized Fluorescent Calcium Carbonate Nanoparticle Loaded with Methotrexate: Future Theranostics for Triple Negative Breast Cancer DOI

Rinki Verma,

Md. Zeyaullah, Virendra Singh

et al.

ACS Biomaterials Science & Engineering, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 30, 2025

Herein, fluorescent calcium carbonate nanoclusters encapsulated with methotrexate (Mtx) and surface functionalized chitosan (25 nm) (@Calmat) have been developed for the imaging treatment of triple-negative breast cancer (TNBC). These biocompatible, pH-sensitive nanoparticles demonstrate significant potential targeted therapy diagnostic applications. The efficacy (NPs) was evaluated in MDA-MB-231 TNBC cell lines. enhanced permeability retention effect facilitated accumulation NPs, tumor-bearing rats, as confirmed by vivo fluorescence imaging. Treatment @Calmat resulted a marked reduction pro-inflammatory cytokines, levels IL-6 (1225 ± 67 pg/mL), IL-1β (379 69 TNF-α (14.1 2 contrast to diseased control group (IL-6: 2223 99; IL-1β: 1632 90; TNF-α: 40 3 pg/mL). A similar trend observed liver kidney function biomarkers. Mechanistic studies revealed that activates Bax/Bcl-2 signaling pathway, leading cycle arrest G1 phase subsequent late-phase apoptosis. As result, tumor inhibition rate reached 88%, 80% treated rats surviving beyond 100 days. findings highlight strong dual-function theranostic agent management TNBC.

Language: Английский

Chitosan Nanoparticles: A Versatile Platform for Biomedical Applications DOI Open Access
Showkeen Muzamil Bashir, Gulzar Ahmed Rather, Ana B. Patrício

et al.

Materials, Journal Year: 2022, Volume and Issue: 15(19), P. 6521 - 6521

Published: Sept. 20, 2022

Chitosan is a biodegradable and biocompatible natural polymer that has been extensively explored in recent decades. The Food Drug Administration approved chitosan for wound treatment nutritional use. Furthermore, paved the way advancements different biomedical applications including as nanocarrier tissue-engineering scaffold. Its antibacterial, antioxidant, haemostatic properties make it an excellent option dressings. Because of its hydrophilic nature, ideal starting material hydrogels. To suit specific application demands, can be combined with fillers, such hydroxyapatite, to modify mechanical characteristics pH-sensitive cationic have made popular choice gene delivery cancer therapy. Thus, use nanoparticles developing novel drug systems received special attention. This review aims provide overview chitosan-based nanoparticles, focusing on their versatile sciences engineering.

Language: Английский

Citations

119

(Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy DOI
Milad Ashrafizadeh, Ali Zarrabi, Ashkan Bigham

et al.

Medicinal Research Reviews, Journal Year: 2023, Volume and Issue: 43(6), P. 2115 - 2176

Published: May 11, 2023

Abstract Breast cancer is the most malignant tumor in women, and there no absolute cure for it. Although treatment modalities including surgery, chemotherapy, radiotherapy are utilized breast cancer, it still a life‐threatening disease humans. Nanomedicine has provided new opportunity treatment, which focus of current study. The nanocarriers deliver chemotherapeutic agents natural products, both increase cytotoxicity against cells prevent development drug resistance. efficacy gene therapy boosted by nanoparticles delivery CRISPR/Cas9, Noncoding RNAs, RNAi, promoting their potential expression regulation. codelivery can exert synergistic impact on tumors enhance cellular uptake via endocytosis. Nanostructures able to induce photothermal photodynamic ablation cell death induction. provide microenvironment remodeling repolarization macrophages antitumor immunity. stimuli‐responsive nanocarriers, pH‐, redox‐, light‐sensitive, mediate targeted suppression tumors. Besides, diagnosis detect biomarkers. Various kinds have been employed therapy, carbon‐, lipid‐, polymeric‐ metal‐based nanostructures, different terms biocompatibility efficiency.

Language: Английский

Citations

97

Recent Advances in Chitosan and its Derivatives in Cancer Treatment DOI Creative Commons
Jingxian Ding,

Yonghong Guo

Frontiers in Pharmacology, Journal Year: 2022, Volume and Issue: 13

Published: April 28, 2022

Cancer has become a main public health issue globally. The conventional treatment measures for cancer include surgery, radiotherapy and chemotherapy. Among the various available measures, chemotherapy is still one of most important treatments patients. However, cancers faces many problems associated with lot adverse effects, which limit its therapeutic potency, low survival quality discount prognosis. In order to decrease these side effects improve effectiveness patient's compliance, more targeted are needed. Sustainable controlled deliveries drugs controllable toxicities expected address hurdles. Chitosan second abundant natural polysaccharide, excellent biocompatibility notable antitumor activity. Its biodegradability, biocompatibility, biodistribution, nontoxicity immunogenicity free have made chitosan widely used polymer in pharmacology, especially oncotherapy. Here, we make brief review achievements derivatives pharmacology special focus on their agents delivery applications, immunomodulation, signal pathway modulation activity highlight role treatment. Despite large number successful studies, commercialization copolymers big challenge. further development polymerization technology may satisfy unmet medical needs.

Language: Английский

Citations

72

Sustainable Biodegradable Biopolymer-Based Nanoparticles for Healthcare Applications DOI Open Access

Nika Kučuk,

Mateja Primožič,

Željko Knez

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(4), P. 3188 - 3188

Published: Feb. 6, 2023

Biopolymeric nanoparticles are gaining importance as nanocarriers for various biomedical applications, enabling long-term and controlled release at the target site. Since they promising delivery systems therapeutic agents offer advantageous properties such biodegradability, biocompatibility, non-toxicity, stability compared to toxic metal nanoparticles, we decided provide an overview on this topic. Therefore, review focuses use of biopolymeric animal, plant, algal, fungal, bacterial origin a sustainable material potential drug systems. A particular focus is encapsulation many different categorized bioactive compounds, drugs, antibiotics, other antimicrobial agents, extracts, essential oils into protein- polysaccharide-based nanocarriers. These show benefits human health, especially successful anticancer activity. The article, divided protein-based further according biopolymer, enables reader select appropriate more easily incorporation desired component. latest research results from last five years in field production loaded with healthcare applications included review.

Language: Английский

Citations

67

Biomaterials for Drug Delivery and Human Applications DOI Open Access
Paolo Trucillo

Materials, Journal Year: 2024, Volume and Issue: 17(2), P. 456 - 456

Published: Jan. 18, 2024

Biomaterials embody a groundbreaking paradigm shift in the field of drug delivery and human applications. Their versatility adaptability have not only enriched therapeutic outcomes but also significantly reduced burden adverse effects. This work serves as comprehensive overview biomaterials, with particular emphasis on their pivotal role delivery, classifying them terms biobased, biodegradable, biocompatible nature, highlighting characteristics advantages. The examination delves into extensive array applications for biomaterials encompassing diverse medical fields such cancer therapy, cardiovascular diseases, neurological disorders, vaccination. explores actual challenges within this domain, including potential toxicity complexity manufacturing processes. These emphasize necessity thorough research continuous development regulatory frameworks. second aim review is to navigate through compelling terrain recent advances prospects envisioning healthcare landscape where they empower precise, targeted, personalized delivery. transform staggering, promise treatments tailored individual patient needs, offering hope improved efficacy, fewer side effects, brighter future practice.

Language: Английский

Citations

55

Amelioration of Cancer Employing Chitosan, Its Derivatives, and Chitosan-Based Nanoparticles: Recent Updates DOI Open Access
Tarun Virmani, Girish Kumar, Ashwani Sharma

et al.

Polymers, Journal Year: 2023, Volume and Issue: 15(13), P. 2928 - 2928

Published: July 1, 2023

The limitations associated with the conventional treatment of cancer have necessitated design and development novel drug delivery systems based mainly on nanotechnology. These include various kinds nanoparticles, such as polymeric solid lipid nanostructured carriers, hydrogels, micelles. Among systems, chitosan-based nanoparticles attracted attention researchers to treat cancer. Chitosan is a polycationic polymer generated from chitin characteristics biocompatibility, biodegradability, non-toxicity, mucoadhesiveness, making it an ideal fabricate systems. However, chitosan poorly soluble in water acidic aqueous solutions. Furthermore, owing presence reactive amino groups, can be chemically modified improve its physiochemical properties. derivatives employed which are used most frequently pharmaceutical sector due their possession nanosize, appropriate pharmacokinetic pharmacodynamic properties, non-immunogenicity, improved stability, loading capacity. capable delivering nucleic acids, chemotherapeutic medicines, bioactives using chitosan. derivative-based targeted specific sites via active passive mechanisms. Based many anticancer drugs now better effectiveness, potency, cytotoxicity, or biocompatibility. tailored derivatives, well use therapy, will examined this review.

Language: Английский

Citations

50

Advances in chitosan-based drug delivery systems: A comprehensive review for therapeutic applications DOI

Ammar Haider,

Shabana I. Khan, Dure Najaf Iqbal

et al.

European Polymer Journal, Journal Year: 2024, Volume and Issue: 210, P. 112983 - 112983

Published: March 26, 2024

Language: Английский

Citations

49

Synthesis and characterization of chitosan/carbon quantum dots/Fe2O3 nanocomposite comprising curcumin for targeted drug delivery in breast cancer therapy DOI
Maryam Zoghi, Mehrab Pourmadadi, Fatemeh Yazdian

et al.

International Journal of Biological Macromolecules, Journal Year: 2023, Volume and Issue: 249, P. 125788 - 125788

Published: July 10, 2023

Language: Английский

Citations

47

Synthesis of a novel pH-responsive Fe3O4/chitosan/agarose double nanoemulsion as a promising Nanocarrier with sustained release of curcumin to treat MCF-7 cell line DOI
Mehrab Pourmadadi, Mohammadjavad Ahmadi, Fatemeh Yazdian

et al.

International Journal of Biological Macromolecules, Journal Year: 2023, Volume and Issue: 235, P. 123786 - 123786

Published: Feb. 23, 2023

Language: Английский

Citations

46

Chitosan-Based Nanoparticles with Optimized Parameters for Targeted Delivery of a Specific Anticancer Drug—A Comprehensive Review DOI Creative Commons
Joanna Kurczewska

Pharmaceutics, Journal Year: 2023, Volume and Issue: 15(2), P. 503 - 503

Published: Feb. 2, 2023

Chitosan is a positively charged polysaccharide obtained through chitin deacetylation. It belongs to group of biodegradable, bioavailable, and non-toxic materials natural origin; thus, it promising matrix for creating delivery systems different active agents. Recently, much attention has been paid nanodelivery as carriers enable better bioavailability, thus higher efficiency the loaded drug. The present review focused on progress in chitosan-based nanoparticles targeted antitumor drugs. paper discusses literature reports from last three years which chitosan were applied substances used therapy potential new drugs with anticancer properties. Special was treatments increase therapeutic effectiveness minimize side effects specific substance.

Language: Английский

Citations

42